InVivo Therapeutics Holdings Corp (NVIVQ)

[BioBull1]

17 months of cash is a big misconception as many are not doing the right math. It would also mean Invivo simply takes their account to zero. A raise would come sooner.

Do not forget, the new cervical trial is starting, oUS sites are ramping up for the INSPIRE trial and more developments with stem cells are only going to increase monthly burn rates beyond the current $1.4M/mo.